Cepheid to Webcast Upcoming Financial Presentations
SUNNYVALE, Calif., Nov. 3, 2011 /PRNewswire/ — Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.
Credit Suisse Healthcare Conference, Phoenix, AZ
Thursday, November 10, 2011 at 2.00 p.m. Mountain Time
Lazard Capital Markets Healthcare Conference, New York, NY
Wednesday, November 16, 2011 at 10.30 a.m. Eastern Time
Piper Jaffray Health Care Conference, New York, NY
Wednesday, November 30, 2011 at 8.00 a.m. Eastern Time
To access the live webcasts for these events, please visit Cepheid’s website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.
About Cepheid
Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company’s systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.
CONTACTS:
For Media Inquiries: For Investor Inquiries:
-------------------- -----------------------
Jared Tipton Jacquie Ross
Cepheid Corporate Cepheid Investor
Communications Relations
Tel: (408) 400-8377 Tel: (408) 400-8329
communications@cepheid.com investor.relations@cepheid.com
SOURCE Cepheid

